We are live on ! Find out more
DCMM

DG Capital Management (Massachusetts) Portfolio holdings

AUM $102M
1-Year Est. Return 29.14%
This Fund
S&P 500
This Quarter Est. Return
+5.34%
1 Year Est. Return
+29.14%
3 Year Est. Return
+96.74%
5 Year Est. Return
10 Year Est. Return
AUM
$164M
AUM Growth
-$11.4M
Cap. Flow
-$17M
Cap. Flow %
-10.36%
Top 10 Hldgs %
31.15%
Holding
75
New
13
Increased
16
Reduced
33
Closed
12

Top Buys

Rank Stock Value
1
GS icon
Goldman Sachs
GS
+$3.57M
2
FSLR icon
First Solar
FSLR
+$2.84M
3
HCA icon
HCA Healthcare
HCA
+$2.73M
4
CYH icon
Community Health Systems
CYH
+$2.31M
5
THC icon
Tenet Healthcare
THC
+$2.14M

Sector Composition

Rank Sector Weight
1 Healthcare 33.73%
2 Technology 21.64%
3 Financials 14.26%
4 Industrials 9.73%
5 Communication Services 9.46%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BIIB icon
1
Biogen
BIIB
$29.9B
$9.23M 5.63%
27,915
+435
+2% +$143K
AMGN icon
2
Amgen
AMGN
$203B
$7.89M 4.81%
56,148
+7,518
+15% +$982K
FDX icon
3
FedEx
FDX
$74.5B
$5.03M 3.07%
31,170
+2,695
+9% +$409K
GILD icon
4
Gilead Sciences
GILD
$161B
$4.64M 2.83%
43,565
-2,250
-5% -$220K
NVS icon
5
Novartis
NVS
$295B
$4.52M 2.76%
53,590
+6,489
+14% +$525K
SNY icon
6
Sanofi
SNY
$104B
$4.26M 2.6%
75,475
+4,700
+7% +$252K
LLY icon
7
Eli Lilly
LLY
$1.07T
$4.2M 2.56%
64,765
+2,735
+4% +$173K
AAL icon
8
American Airlines Group
AAL
$9.58B
$3.81M 2.33%
107,477
-44,755
-29% -$1.76M
MU icon
9
Micron Technology
MU
$1.04T
$3.75M 2.29%
109,560
-21,580
-16% -$699K
GS icon
10
Goldman Sachs
GS
$313B
$3.73M 2.27%
+20,299
New +$3.57M
MJN
11
DELISTED
Mead Johnson Nutrition Company
MJN
$3.72M 2.27%
38,695
+1,585
+4% +$150K
GOOG icon
12
Alphabet (Google) Class C
GOOG
$3.9T
$3.72M 2.27%
128,071
-5,414
-4% -$157K
META icon
13
Meta Platforms (Facebook)
META
$1.51T
$3.71M 2.26%
46,913
+4,574
+11% +$336K
NXPI icon
14
NXP Semiconductors
NXPI
$68B
$3.63M 2.21%
53,035
-4,355
-8% -$290K
MSFT icon
15
Microsoft
MSFT
$2.84T
$3.61M 2.2%
77,950
+1,195
+2% +$53.3K
DAL icon
16
Delta Air Lines
DAL
$55.9B
$3.48M 2.12%
96,245
-1,165
-1% -$44.5K
MS icon
17
Morgan Stanley
MS
$337B
$3.26M 1.99%
94,350
+4,685
+5% +$156K
CB icon
18
Chubb
CB
$140B
$2.93M 1.79%
27,965
HCA icon
19
HCA Healthcare
HCA
$84.8B
$2.91M 1.78%
+41,290
New +$2.73M
ABBV icon
20
AbbVie
ABBV
$458B
$2.85M 1.74%
49,310
-2,940
-6% -$163K
NOK icon
21
Nokia
NOK
$50.8B
$2.81M 1.71%
332,035
+36,095
+12% +$290K
MON
22
DELISTED
Monsanto Co
MON
$2.8M 1.71%
24,915
-4,835
-16% -$565K
TXN icon
23
Texas Instruments
TXN
$255B
$2.8M 1.71%
58,745
-16,010
-21% -$767K
AGN
24
DELISTED
Allergan plc
AGN
$2.77M 1.69%
11,473
-2,935
-20% -$657K
FSLR icon
25
First Solar
FSLR
$21.8B
$2.76M 1.68%
+41,965
New +$2.84M

Similar funds

DG Capital Management (Massachusetts)'s Q3 2014 Portfolio in Review

As of Q3 2014, DG Capital Management (Massachusetts) held 75 positions worth $164M, down 6.5% from $175M the previous quarter. Its ten largest holdings account for 31% of the portfolio.

DG Capital Management (Massachusetts) withdrew a net $17M in Q3 2014, closing 12 positions and reducing 33 holdings. Its most notable exit was Las Vegas Sands, an estimated $3.77M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 34% of assets, up from 25% a quarter earlier, followed by Technology and Financials.

Against the trend, DG Capital Management (Massachusetts) opened a new position in Goldman Sachs worth $3.73M.

  • DG Capital Management (Massachusetts)'s largest Q3 2014 buy was Goldman Sachs: 20,299 shares worth $3.73M.
  • DG Capital Management (Massachusetts) added most to Amgen in Q3 2014, an estimated $982K increase.
  • DG Capital Management (Massachusetts)'s biggest Q3 2014 reduction was Mondelez International, cutting an estimated $2.66M.
  • DG Capital Management (Massachusetts) fully exited Las Vegas Sands in Q3 2014, selling an estimated $3.77M.
  • DG Capital Management (Massachusetts)'s ten largest holdings make up 31% of its $164M portfolio in Q3 2014.
  • DG Capital Management (Massachusetts) opened 13 new positions and closed 12 in Q3 2014.
  • DG Capital Management (Massachusetts)'s portfolio value fell 6.5% quarter-over-quarter to $164M.

Based on DG Capital Management (Massachusetts)'s 13F filing for Q3 2014, filed 12 Nov 2014.